Why the study?
Does MHC class I and class II expression on cardiac biopsies predict or correlate with cardiac rejection episodes posttransplantation?
Does MHC class I and class II expression on cardiac biopsies predict or correlate with cardiac rejection episodes posttransplantation?
Answers are grounded in this paper and cite their sources.
MHC class I and II expression on cardiac biopsies may serve as an early marker for monitoring cardiac rejection episodes posttransplantation.
A total of 85 cardiac biopsies from patients 23-265 days posttransplant were studied for the correlation of the rejection grade score with the level of major histocompatibility complex (MHC) class I and class II expression on cardiac myocytes and endothelial cells, the quantitative level of leukocytic infiltrate, and the immunophenotype of the leukocytes. Results indicate a lack of absolute correlation between rejection grade scores and levels of MHC antigen expression. Further, a lack of absolute correlation was also seen with quantitation of leukocytic infiltrates and relative levels of MHC antigen expression. Of great interest was our preliminary finding that as early as 4 weeks prior to a rejection episode scored by routine histological criteria as grade 4, cardiac biopsy from the patient demonstrated high levels of MHC class I and class II expression. Similar increases of MHC antigen expression prior to an increase in histological rejection score grades were also noted in serial biopsies of 2 other patients. These data suggest that it may be quite useful to examine levels of MHC antigens on cardiac biopsies posttransplantation as an additional parameter for monitoring of cardiac rejection episodes.
No takes yet. Share an insight, caveat, or question.
Ahmed‐Ansari et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: